"Ramipril" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A long-acting angiotensin-converting enzyme inhibitor. It is a prodrug that is transformed in the liver to its active metabolite ramiprilat.
| Descriptor ID |
D017257
|
| MeSH Number(s) |
D03.633.100.893
|
| Concept/Terms |
Triatec- Triatec
- Altace
- Zabien
- Ramace
- Tritace
- Acovil
- Delix
|
Below are MeSH descriptors whose meaning is more general than "Ramipril".
Below are MeSH descriptors whose meaning is more specific than "Ramipril".
This graph shows the total number of publications written about "Ramipril" by people in this website by year, and whether "Ramipril" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2008 | 2 | 0 | 2 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2014 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ramipril" by people in Profiles.
-
Systolic blood pressure target levels: evidence for benefits in stroke. Hypertension. 2015 Jan; 65(1):39-40.
-
Recent clinical trials. J Am Soc Hypertens. 2014 Oct; 8(10):770-4; quiz 775-6.
-
Comparative efficacy of aliskiren monotherapy and ramipril monotherapy in patients with stage 2 systolic hypertension: subgroup analysis of a double-blind, active comparator trial. Cardiovasc Ther. 2010 Dec; 28(6):344-9.
-
Lessons learned from the ONTARGET and TRANSCEND trials. Curr Atheroscler Rep. 2009 Sep; 11(5):371-6.
-
Comparative effectiveness of angiotensin-converting-enzyme inhibitors: is an ACE always an ace? CMAJ. 2008 May 06; 178(10):1316-9.
-
Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial. J Hypertens. 2008 Mar; 26(3):589-99.
-
Effect of high dose ramipril with or without indomethacin on glomerular selectivity. Kidney Int. 2002 Sep; 62(3):1010-9.
-
Reciprocal role of the AT1 receptor in modulating renal and neuronal AT1 mRNA expression. J Am Soc Nephrol. 1999 Jan; 10 Suppl 11:S18-22.
-
Regulation of ANG II receptor in hypertension: role of ANG II. Am J Physiol. 1996 Jul; 271(1 Pt 2):H120-5.
-
Ramipril decreases chlorthalidone-induced loss of magnesium and potassium in hypertensive patients. J Clin Pharmacol. 1995 Dec; 35(12):1150-5.